Camille L Bedrosian Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Camille L Bedrosian is Director of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,000 shares of RYTM, which is worth approximately $123,180. The most recent transaction as insider was on Jun 21, 2024, when has been sold 3,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K

n/a 3M change

n/a 12M change

Total Value Held $123,180

Camille L Bedrosian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 21 2024	BUY Exercise of conversion of derivative security	-	3,000 Added 50.0%	3,000 Common Stock

Also insider at

CRNX

Crinetics Pharmaceuticals, Inc. Healthcare

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

EVP and Chief Medical Officer

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

Chief Medical Officer

CLB